A Randomized Controlled Trial of N-Acetylcysteine in Clozapine-Resistant Schizophrenia - Psychiatric Times
8/18/2022 12:00:00 AM2 years 8 months ago
by Brian Miller, MD, PhD, MPH
by Brian Miller, MD, PhD, MPH
Getting the “NAC” of treating negative symptoms: Researchers performed a randomized controlled trial of N-acetylcysteine in clozapine-resistant schizophrenia.
CASE VIGNETTE Mr Charles is a 34-year-old Caucasian male with a 16-year history of schizophrenia. He has been on clozapine since age 21, at a current dose of 400 mg at bedtime. He previously took up… [+7325 chars]
full article...